ArticleCureus2025
Unshrinking the Lung: Successful Improvement of Shrinking Lung Syndrome in Systemic Lupus Erythematosus Through Non-invasive Ventilation and Respiratory Rehabilitation.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Suspected shrinking lung syndrome: a rare pulmonary manifestation of systemic lupus erythematosus-a case-based review of an underrecognized condition.Rheumatology international · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Shrinking lung syndrome (SLS) is a rare pulmonary manifestation of systemic lupus erythematosus (SLE), characterized by progressive dyspnea and severe restrictive ventilatory impairment. The pathophysiology remains unclear, with proposed mechanisms involving diaphragmatic dysfunction, pleural inflammation, and neuromuscular impairment. We report the case of a 38-year-old non-smoking woman with a history of SLE, presenting with worsening dyspnea and hypoxemic respiratory failure. Pulmonary function tests revealed a severe restrictive pattern, and nocturnal oximetry demonstrated significant desaturation. Imaging showed no interstitial lung disease. A structured respiratory rehabilitation program, combined with nocturnal non-invasive ventilation (NIV) using intelligent volume-assured pressure support, resulted in substantial clinical and functional improvement. Over six months, the patient experienced significant symptom relief, pulmonary function stabilization, and resolution of nocturnal desaturation. This case highlights the potential role of NIV and pulmonary rehabilitation in improving respiratory function and quality of life in patients with SLS. Early diagnosis and a multidisciplinary approach are fundamental in optimizing patient outcomes. Further research is needed to establish standardized treatment protocols for SLS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.